Head of Investor Relations
Fulgent Genetics, Inc. (FLGT)Equibles does not estimate personal net worth.
Get an email with a short summary when Fulgent Genetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FLGT alertsMelanie Solomon is recorded as Head of Investor Relations at Fulgent Genetics, Inc. (FLGT). Melanie Solomon has spoken on 10 earnings calls across 1 company, most recently for Fulgent Genetics, Inc. on May 2, 2025. Fulgent Genetics, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Fulgent Genetics, Inc. includes Ming Hsieh (CEO), Paul Kim (CFO), Jian Xie (COO) and 6 others.
“Greetings and welcome to the Fulgent Genetics, Inc. Q1 2025 Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation.”
“Morning, and welcome to the Fulgent Genetics, Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call. On the call today are Ming Hsieh, Chief Executive Officer, Paul Kim, Chief Financial Officer, and Brandon Perthuis, Chief Commercial Officer.”
“Good morning and welcome to the Fulgent third quarter 2024 financial results conference call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; and Brandon Perthuis, Chief Commercial Officer.”
“Good morning and welcome to the Fulgent second quarter of 2024 financial results conference call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; and Brandon Perthuis, Chief Commercial Officer.”
“Good morning, and welcome to the Fulgent First Quarter 2024 Financial Results Conference Call. On the call are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; and Brandon Perthuis, Chief Commercial Officer.”
Diagnostics & Research · Healthcare
Head of Investor Relations
